|Year : 2022 | Volume
| Issue : 4 | Page : 287-290
One-Step Method in Creation of Artificial Ascites
Tienshin Chou, Cho-Li Yen, Li-Wei Chen, Cheng-Hung Chien
Department of Hepatogastroenterology, Liver Research Unit, Keelung Chang-Gung Memorial Hospital, Keelung, Taiwan
|Date of Submission||13-Feb-2022|
|Date of Decision||15-Apr-2022|
|Date of Acceptance||19-May-2022|
|Date of Web Publication||16-Aug-2022|
Dr. Cho-Li Yen
Department of Hepatogastroenterology, Keelung Chang-Gung Memorial Hospital, No. 222, Mai-Chin Road, Keelung 204
Source of Support: None, Conflict of Interest: None
Background: The study aims to improve the success rate and the rapidity in creating artificial ascites before starting the treatment for subcapsular hepatocellular carcinomas. Methods: Two hundred and forty-six consecutive hepatocellular carcinoma patients who required the instillation of artificial ascites for better visualization or prevention from organ injury were recruited between November 2011 and September 2017. Initially, 95 patients were using the Seldinger technique, while the remaining 151 patients were using the one-step method. The proportions of patients who had undergone surgery, transarterial chemoembolization, or radiofrequency ablation therapy before performing artificial ascites infusion were 11.6% (11/95), 3% (3/95), and 37% (35/95) in the Seldinger group, and 15.9% (24/151), 15.2% (23/151), and 52.3% (79/151), respectively, in the one-step group. Results: The complete success rate, partial success rate, and failure rate in creating artificial ascites using the Seldinger technique and the one-step method were 76.8% (73/95), 11.6% (11/95), 11.6% (11/95) and 88.1% (133/151), 7.9% (12/151), 4% (6/151), respectively. The complete success rate was significantly higher in the one-step method group (P < 0.05) than that of the Seldinger group. The mean time required from starting the procedure to successful intraperitoneal instillation of glucose water was 145.79 ± 133.37 s in the one-step method, which was statistically shorter than that of 238.68 ± 95.58 s in the Seldinger group (P < 0.05). Conclusion: The one-step method has a higher success rate than the Seldinger method in creating artificial ascites and is faster, especially in treatment-experienced patients.
Keywords: Artificial ascites, hepatocellular carcinoma, one-step method, radiofrequency ablation
|How to cite this article:|
Chou T, Yen CL, Chen LW, Chien CH. One-Step Method in Creation of Artificial Ascites. J Med Ultrasound 2022;30:287-90
| Introduction|| |
Radiofrequency ablation (RFA) therapy has been widely accepted as an effective modality for the treatment of hepatocellular carcinomas, and the response rates were high with few complications.,,, Patients with hepatocellular carcinoma at the early stage can be treated with RFA, and the 5-year survival rates were between 50% and 70%.,
Percutaneous ultrasonography-guided RFA therapy is one of the most frequently used methods in treating hepatocellular carcinoma. There are a number of drawbacks, especially when the tumors are adjacent to the intestine, stomach, or abutting the dome. The reported complication rates of intestinal perforation varied from 0.5% to 0.7%., Artificial effusion, or artificial ascites,, was used to increase the visibility of the tumors near the dome as well as to avoid injury to the digestive tract. The success rates in the creation of artificial ascites were between 88% and 97%.,, The Seldinger technique has been adopted for the placement of the angiosheath. The patients who underwent artificial ascites infusion were requested to hold their breath, and the outer sheaths were placed in the peritoneal cavity when the patients exhaled. However, when the patients were under deep anesthesia, they were unable to cooperate. To overcome these shortcomings, we conducted this study using the one-step method to improve the effectiveness in creating artificial ascites.
| Materials and Methods|| |
The study was approved by the Institutional Review Board of Keelung Chang Gung Memorial Hospital (IRB No. 2107130069). Informed consents were obtained from all patients before starting treatment. The procedures for the induction of artificial ascites were performed by the same hepatologist who had experience in sonography-guided intervention for more than 20 years.
The diagnosis of hepatocellular carcinoma, conformed to the AASLD criteria, was confirmed by percutaneous liver biopsy or based on at least one characteristic imaging finding with computed tomography or magnetic resonance imaging. All the patients were Child–Pugh class A or B liver cirrhotic patients with the values of prothrombin time <1.7 (international normalized ratio), and the platelet counts >60,000 cells/mm3.
Between November 2011 and September 2017, a total of 246 patients who had undergone artificial ascites infusion before RFA therapy were enrolled. The Seldinger method was adopted in 95 patients and the one-step method was implemented in 151 patients.
Creating artificial ascites
All patients were sedated with 100 μg of fentanyl or 50 mg of Demerol in addition to 5 mg of midazolam intravenously before treatment. Local anesthesia using 2% lidocaine solutions of variable amounts, as required, was injected to the puncture sites under the guidance of sonography.
The procedure of the one-step method was implemented as described below. After taking out the inner stylet from an 18 gauge Chiba needle, a guide wire was threaded into the hollow needle. The threaded hollow needle was punctured through the skin. Upon reaching the capsule of liver, as can be seen on ultrasonography, the resistance from the parietal peritoneum could be felt. With a gentle push on the threaded needle, the resistance was released and the needle was placed just above the liver capsule. The guide wire was pushed beyond the tip of the threaded needle [Figure 1]. As the guide wire was placed correctly in the abdominal cavity, the resistance was minimal. The guide wire could be demonstrated on ultrasound and the liver capsule was usually pressed slightly downward [Figure 2]. The angiosheath was then passed over the guide wire into the skin and reached the intraperitoneal space. After withdrawal of the guide wire, D5/W was instilled through the angiosheath to create artificial ascites. If the guide wire was misplaced in the liver parenchyma, an echogenic linear structure could be seen on ultrasonography [Figure 3]. The tip of the threaded needle was pulled back a little bit to allow for the replacement of the guide wire into the intraperitoneal cavity.
|Figure 1: A guide wire is threaded into the hollow chamber of an 18 gauge Chiba needle with the wire (arrow) pushed beyond the tip of the needle|
Click here to view
|Figure 2: The guide wire was placed correctly in the peritoneal space (arrow A). The liver capsule was pressed down by the wire (arrow B)|
Click here to view
|Figure 3: The guide wire is misplaced under the liver capsule (arrow A) in the liver parenchyma (arrow B)|
Click here to view
A complete success was defined as the instillation of adequate water to separate the target tumor from the adjacent organ; a partial success was defined as the incomplete separation of the tumor from the adjacent organ despite sufficient amount of ascites instilled; and a failure was defined as the subcutaneous or intrapleural instillation of water without reaching the desired region.
The time required to complete the artificial ascites infusion, and the success rates were analyzed and compared between the one-step method group and the Seldinger group using Student's t-test and the χ2 test or Fisher's exact test. P < 0.05 was considered statistically significant.
| Results|| |
The proportions of patients who had undergone surgery, transarterial chemoembolization (TACE), or RFA therapy before the procedures were 11% (11/9), 3% (3/95), and 37% (35/95) in the Seldinger group, and 15.9% (24/151), 15.2% (23/151), and 52.3% (79/151) in the one-step method group, respectively. In total, 51.6% (49/95) in the Seldinger group and 83.4% (126/151) in the one-step group had undergone previous procedures. The patients using the one-step method had undergone more previous treatment than the Seldinger group had statistically undergone (P < 0.05).
For the one-step method, the time required from the beginning to the completion of the procedure ranged from 40.0 s to 920.0 s with a mean and standard deviation of 145.79 ± 133.37 s. In patients using the Seldinger method, the time required from the beginning to the completion of the procedure ranged from 150.0 s to 720.0 s with a mean and standard deviation of 238.68 ± 95.55 s. The time required for the one-step method was significantly shorter than that of the Seldinger method (P < 0.05).
The complete success rate, partial success rate, and the failure rate for the Seldinger technique and the one-step method were 76.8% (73/95), 11.6% (11/95), 11.6% (11/95) and 88.1% (133/151), 7.9% (12/151), 4.% (6/151), respectively. In total, the success rate (complete success plus partial success) of the one-step method was 96%, which is significantly better than that of the 88.4% in the Seldinger group (P < 0.05).
In subgroup analysis, the success rate of 95.25% (120/126) in treatment-experienced patients using the one-step method was statistically higher than that of 85.7% (54/63) in the Seldinger group (P = 0.022). For treatment naïve patients, the success rates of 100% (25/25) and 93.7% (30/32) for the one-step method and the Seldinger group, respectively, were not different statistically.
A total of 11 patients (7.3%) demonstrated ultrasonography detectable right pleural effusions after the one-step method and required a pigtail catheter placement to relieve symptoms.
| Discussion|| |
Before the introduction of artificial ascites, the frequency of diaphragm injury after percutaneous RFA for hepatic tumors adjacent to the diaphragm was reported to be 17%. Artificial ascites infusion of saline or glucose water into a pocket created by the injection of lidocaine was first reported by Raman in the animal study. The injury of the diaphragm was reduced to grade 0 in 65% of experimental animals. However, the creation of artificial ascites using lidocaine pocket has several drawbacks including the difficulty to maintain the injection needle in place and the risk of injury to the liver or the adjacent organs during RF deployment or treatment and most importantly the collection of artificial ascites may not be present in the desired place. With either the one-step method or the Seldinger technique, a catheter instead of the injection needle can be placed intraperitoneally nearest to the tumor to be ablated and during treatment; the amounts of artificial ascites required can be easily adjusted.
The Seldinger technique has several technical limitations when creating artificial ascites. The method requires the patients to hold their breath during needle punctures and exhale when advancing the external sheath. However, this practice is difficult to put into place when the patients are under heavy sedation or general anesthesia. In the presence of peritoneal adhesion resulting from previous surgery, thermal ablation therapy or TACE, the placement of an external sheath with the Seldinger method, is more difficult than the advancement of a guide wire during the performance of the one-step method because the space between the parietal peritoneum and the liver capsule is narrow and the sheath is wider than the guide wire.
One more advantage of the one-step method is that the guide wire is more readily visible on sonography than the plastic sheath. However, severe adhesion is still a main obstacle in advancing the guide wire with the one-step method. The time required to achieve a successful artificial creation of ascites using the one-step method was 145.79 s in this study, which was significantly shorter than that of the Seldinger method because the one-step method omitted the step of placing the over-sheath. As a result, the one-step method shortened the time required to achieve a successful infusion of the artificial ascites.
The success rate was 96% with the one-step method in this study, which was compatible with the rates of 84.1%–100% in previous reports.,,
The concern that the guide wire might penetrate the liver parenchyma was minimized by the clear demonstration of the guide-wire under ultrasonography and the risk of penetration of liver parenchyma was avoided by drawing back the threaded needle when the wire was present in the liver parenchyma.
In summary, the creation of artificial ascites with the Seldinger method requires the cooperation of conscious patients and has the disadvantage of poor visualization of the sheath during placement of the guide wire on sonography. The introduction of artificial ascites with the one-step method is safe and faster than the conventional Seldinger method. The guide wire can be seen more readily on sonography, but adhesion from previous procedures including surgery, RFA, or HACE still interferes with the success rate. The risk of introducing the guide wire into the liver can be minimized as the guide wire can be visualized clearly on ultrasonography while performing the one-step method.
Financial support and sponsorship
Conflicts of interest
Prof. Cho-Li Yen, an editorial board member at Journal of Medical Ultrasound, had no role in the peer review process of or decision to publish this article. The other authors decalared no conflicts of interest in writing this paper.
| References|| |
Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2.
Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, et al.
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008;47:82-9.
Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: Current status. World J Radiol 2010;2:417-24.
Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012;379:1245-55.
Rhim H, Lim HK, Choi D. Current status of radiofrequency ablation of hepatocellular carcinoma. World J Gastrointest Surg 2010;2:128-36.
Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, et al.
Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002;89:1206-22.
Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complications encountered in a multicenter study. Radiology 2003;226:441-51.
Koda M, Ueki M, Maeda Y, Mimura K, Okamoto K, Matsunaga Y, et al.
Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. AJR Am J Roentgenol 2004;183:583-8.
Fukuno H, Tamaki K, Urata M, Kohno N, Shimizu I, Nomura M, et al.
Influence of an artificial pleural effusion technique on cardio-pulmonary function and autonomic activity. J Med Invest 2007;54:48-53.
Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR Am J Roentgenol 2008;190:91-8.
Song I, Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: Safety and technical efficacy in 143 patients. Eur Radiol 2009;19:2630-40.
Nishimura M, Nouso K, Kariyama K, Wakuta A, Kishida M, Wada N, et al.
Safety and efficacy of radiofrequency ablation with artificial ascites for hepatocellular carcinoma. Acta Med Okayama 2012;66:279-84.
Head HW, Dodd GD 3rd
, Dalrymple NC, Prasad SR, El-Merhi FM, Freckleton MW, et al.
Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: Frequency of diaphragmatic injury. Radiology 2007;243:877-84.
Raman SS, Lu DS, Vodopich DJ, Sayre J, Lassman C. Minimizing diaphragmatic injury during radio-frequency ablation: Efficacy of subphrenic peritoneal saline injection in a porcine model. Radiology 2002;222:819-23.
Rhim H, Lim HK. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: The value of artificial ascites. Abdom Imaging 2009;34:371-80.
Liu LN, Xu HX, Lu MD, Xie XY. Percutaneous ultrasound-guided thermal ablation for liver tumor with artificial pleural effusion or ascites. Chin J Cancer 2010;29:830-5.
Zhang M, Liang P, Cheng ZG, Yu XL, Han ZY, Yu J. Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract. Int J Hyperthermia 2014;30:134-41.
[Figure 1], [Figure 2], [Figure 3]